BORR vs DEC

BORR's Piotroski F-Score of 4/9 indicates borderline financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades below its Graham Number of $5.01 at $4.47, suggesting modest undervaluation, though forward P/E of -47.51 signals expected earnings deterioration. Strong operating and gross margins contrast with high debt/equity of 1.80 and inconsistent earnings growth, particularly the recent Q/Q EPS decline of -35.7%. Technical trend is weak at 10/100, but dividend strength and insider sentiment are below average, contributing to a cautious outlook.

DEC presents a classic deep-value opportunity, trading at a significant discount to its Graham Number ($36.29) and Intrinsic Value ($32.06). While the Piotroski F-Score of 5/9 indicates stable financial health, the company carries high leverage (Debt/Equity 3.04) and weak short-term liquidity (Current Ratio 0.60). However, these risks are offset by exceptional profitability metrics, including an ROE of 48.60% and explosive revenue growth of 95.70%. The combination of a very low P/E (3.38) and a sustainable high-yield dividend makes it an attractive risk-reward play despite bearish insider activity.